Hospital Italiano de Buenos Aires
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires F.D., Argentina4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| One Health Determinants of Rectal Colonization by ESBL-Producing Enterobacterales in the Community | Antimicrobial Resistance (AMR); Carbapenemase-Producing Enterobacterales (CPE) Colonization; Carbapenemase-Producing Enterobacteriaceae; Carbapenemase-Producing Enterobacteriaceae (CPE); ESBL; Environmental Exposure; Gut Microbiota Dysbiosis | Enrolling by invitation | Not stated | 2026-09-14 | NCT07818109 | |
| CMV Refractory and Resistant Infection in Solid Organ Transplant Recipients in Argentina | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Not yet recruiting | Not stated | 2026-08-26 | NCT07787767 | |
| Correlation Between Carbapenemase-Producing Enterobacterales Load, Environmental Contamination, and Transmission in Critical Care Units | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, nosocomial infection | Not yet recruiting | Not stated | 2026-07-06 | NCT07685132 | |
| A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Active, not recruiting | Phase 3 | 2026-03-25 | NCT06445023 |